References:
1. Amchentsev A, Kurugundla N, Saleh AG. Aspergillus-related lung disease. Respiratory Medicine CME. 2008;1(3):205–15.
2. Patterson TF, Thompson III GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2016;63(4):e1–60.
3. Young RC, Bennett JE, Vogel CL, Carbone PP, Devita VT. The spectrum of the disease in 98 patients. Medicine. 1970;49(2):147–73.
4. Kradin RL, Mark EJ. The pathology of pulmonary disorders due to Aspergillus spp. Arch Pathol Lab Med. 2008;132(4):606–14.
5. Slavin RG, Stanczyk DJ, Lonigro AJ, Broun Sr GO. Allergic bronchopulmonary aspergillosis - A north American rarity: Clinical and immunologic characteristics. The Am. J. Med. 1969;47(2):306–13.
6. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156–74.
7. Ryu JH, Swensen SJ. Cystic and cavitary lung diseases: Focal and diffuse. In: Mayo Clinic Proceedings. Elsevier; 2003. p. 744–52.
8. Giron JM, Poey CG, Fajadet PP, Balagner GB, Assoun JA, Richardi GR, et al. Inoperable pulmonary aspergilloma: Percutaneous CT-guided injection with glycerin and amphotericin B paste in 15 cases. Radiology. 1993;188(3):825–7.
9. Li W, Shetty AK, Salih ZT. Aspergillus fumigatus in a fine needle aspiration of a cavitary lung lesion. Clin. Case Rep. 2018;6(12):2475.
10. Sharma S, Gupta P, Gupta N, Lal A, Behera D, Rajwanshi A. Pulmonary infections in immunocompromised patients: The role of image‐guided fine needle aspiration cytology. Cytopathology. 2017;28(1):46–54.